CD34 and acute lymphoblastic leukemia: This finding demonstrates that a small amount of Val-ILs (~0.4 μL diluted in one mL of cell culture) was sufficient to eradicate all malignant B-ALL cells, leaving the CD34+ HSC unharmed.